Ubs downgrades Axis Bank to 'neutral' from 'buy'
UBS downgraded Axis Bank to ``neutral'' from ``buy'', citing ``increasing'' quality risks, ``muted'' earnings growth and a 28 per cent share price increase in the Indian lender so far this year.
Bank of America Merrill Lynch reported on Monday that they have downgraded biopharmaceutical company, Bristol Myers Squibb Co. to ``Neutral.''